After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Stocks remain very unconcerned about rates, despite the odds of a fall increase slightly rising.
Amgen (AMGN) reported 2016 second quarter earnings after the closing bell today that beat analysts' expectations.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Amgen investors have had a rough ride. The stock is down about 3% year to date, but the second half of the year could get interesting.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.